Drug titration patterns and HbA 1c levels in type 2 diabetes.

ABSTRACT:

Objective

To evaluate oral antidiabetes drug (OAD) use, haemoglobin A(1c) (HbA(1c)) testing and glycaemic control in type 2 diabetes patients.

Study design

Retrospective analysis based on claims data from the Integrated Healthcare Information Services (IHCIS) National Managed Care Benchmark Database.

Methods

OAD use and HbA(1c) testing were analysed for patients with >or= 2 claims indicating diagnosis of type 2 diabetes and >or= 1 90-day OAD treatment period between 1 January, 2000 and 30 June, 2006. Likelihood of HbA(1c) testing was examined using multivariable logistic regression analyses, adjusting for OAD regimen and patients' sociodemographical characteristics.

Results

Patients were classified based on initial OAD regimen: metformin (MET) (n = 22,203; 41.3

SUBMITTER: Maclean JR 

PROVIDER: S-EPMC2984545 | biostudies-literature | 2009 Jul

REPOSITORIES: biostudies-literature